Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Future outlook for OTC examination (test)].

Takeyoshi Urata1, Ikunosuke Sakurabayashi

  • 1Matsumotokiyoshi Co., Ltd. Matsudo 270-8501.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|February 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel artificial stool material for external quality assurance (EQA) on a fecal immunochemical test for hemoglobin (FIT): The confirmed utility of stable hemoglobin and an internal standard material.

Clinica chimica acta; international journal of clinical chemistry·2018
Same author

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.

Lipids in health and disease·2017
Same author

The development of an artificial stool usable for the surveillance of faecal haemoglobin testing.

Annals of clinical biochemistry·2017
Same author

A Case of Waldenstrom Macroglobulinemia with Temporary Appearance of 7S IgM Half Molecule.

Clinical laboratory·2017
Same author

Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma.

Scientific reports·2016
Same author

Difference in bias approach for commutability assessment: application to frozen pools of human serum measured by 8 direct methods for HDL and LDL cholesterol.

Clinical chemistry·2015

The study highlights the need for accessible over-the-counter (OTC) diagnostic tests for home use, including metabolic syndrome markers and early cancer detection. These simple, rapid examinations support primary disease prevention and remote healthcare in Japan.

Area of Science:

  • Biomedical diagnostics
  • Preventive medicine
  • Health technology

Background:

  • Growing emphasis on primary disease prevention necessitates accessible diagnostic tools.
  • Current over-the-counter (OTC) testing landscape and upcoming regulatory changes in Japan.
  • Increasing demand for remote healthcare solutions and home-based examinations.

Purpose of the Study:

  • To identify and discuss simple, rapid, home-based examination items suitable for commercialization as Switch OTC products.
  • To explore the epidemiological background and rationale for adopting these tests.
  • To emphasize the importance of early detection for various health conditions.

Main Methods:

  • Review of established technologies for home-based testing.
  • Discussion of specific biomarkers and diagnostic methods.

Related Experiment Videos

  • Analysis of market potential and regulatory considerations for OTC products.

    • Main Results:

    • Identification of key home-use tests for metabolic syndrome: visceral fat rate, blood/urinary glucose, urinary microalbumin, and early morning blood pressure.
    • Emphasis on cancer screening: fecal occult blood test for colorectal cancer, Helicobacter pylori testing, prostate-specific antigen (PSA), and Chlamydia testing.
    • Validation of these tests as suitable for OTC commercialization and widespread population use.

    Conclusions:

    • Simple, rapid OTC tests are crucial for primary disease prevention and remote healthcare.
    • Commercialization of specific tests for metabolic syndrome, cancer, and infectious diseases is recommended.
    • These home-based examinations can empower individuals and improve public health outcomes in Japan.